What are the symptoms of high cholesterol in women?

Are there symptoms of high cholesterol in women that you can feel?

For most women there are none to feel, whatever the number. That is common and nothing to be alarmed by: feeling well and having a raised result can go together, so the result, rather than how you feel, is the useful signal.

What raises it is usually a mix of things you can't feel either: family history, age, the hormone shift around menopause, food pattern and smoking. Family history is the one that moves the AHA schedule, which suggests testing more often with a family history and earlier if a close relative had early heart disease. It's worth asking relatives what they know, gently.

Lp(a) sits a little apart from the rest of the panel. Levels are largely genetic, which is why the 2026 ACC/AHA guideline recommends measuring it at least once in adulthood and why repeat testing is generally not needed. If it is not on your results, it is a reasonable thing to ask about.

Why does cholesterol rise in women, and when?

Of those causes, menopause is the one particular to women. The NIH National Heart, Lung, and Blood Institute (NHLBI, 2024) notes that after menopause total and LDL cholesterol usually rise and HDL usually falls. It offers a likely reason and not a certain one: lower levels of female hormones may no longer give the same protection. The NHS, for its part, lists being post-menopausal as a risk factor.

The change starts earlier. In perimenopause, LDL cholesterol and insulin resistance both rise while cardiovascular risk climbs, which is why checks of cholesterol, blood sugar and blood pressure sit together at this stage, and why a lipid panel is often read alongside HbA1c.

Around the final period the change is sharper. Matthews et al. (2009), reporting in the Journal of the American College of Cardiology from SWAN (the Study of Women's Health Across the Nation), which followed women through the transition, found that LDL cholesterol jumps around the final period and that heart disease risk rises steadily from there. That can be why a result that has been steady for years starts to look different, without anything else in your life having changed.

After menopause, blood pressure, cholesterol and heart disease risk keep rising with age, so regular checks, treatment when needed, exercise and diet all have a place. Treatment is weighed against overall heart risk and not a single reading: the 2026 ACC/AHA guideline sets its LDL goals by risk level, and statins are offered on that basis. One cholesterol number is part of the decision, not the whole of it.

What are normal cholesterol levels for women, and how often are they checked?

Normal cholesterol levels for women are written in different units in each country. In the US, MedlinePlus (2025) gives guide levels for adult women of total cholesterol under 200 mg/dL, LDL under 100 and non-HDL under 130; in the UK, the NHS guide (2024) is total cholesterol below 5 mmol/L and non-HDL below 4 mmol/L. HDL, the one where higher is better, has its own line for women: under 50 mg/dL counts as low in the US, and the NHS guide is above 1.2 mmol/L. A personal goal may be set lower depending on overall heart risk.

On timing, the AHA's every 4–6 years is the general rule from 20. MedlinePlus sets it out by age: every 5 years for ages 20–65, with women aged 55–65 tested every 1–2 years, and yearly after 65. Many women find it easiest to have cholesterol checked at the same visit as blood pressure, and our page on normal blood pressure for women covers those figures.

What the research shows about Lp(a) and heart risk, and what it does not

A raised Lp(a) is a long-range signal, not an emergency. The 2026 ACC/AHA guideline links a level of 125 nmol/L or more (50 mg/dL or more) with about 1.4 times the long-term risk of heart attack or stroke. That is a multiple of your own starting risk, so what it means depends on the rest of your picture.

Starting risk is estimated with a calculator. The guideline now uses one called PREVENT, which covers ages 30–79 and replaces an older tool that tended to overestimate, so a risk figure worked out some years ago may look different if it is run again.

The guideline also counts parts of a woman's own history as risk enhancers: early menopause, preeclampsia and gestational diabetes. They are worth mentioning when a result is discussed. It adds that most lipid-lowering drugs are deferred during conception, pregnancy and lactation, so pregnancy plans are worth raising with your OB-GYN (US) or GP (UK).

What none of this research does is predict one woman's future. SWAN describes a pattern seen across many women, and guideline goals and risk multiples are drawn from large groups. They frame a conversation about your own numbers, family history and preferences.

Next steps

A good place to start is a lipid panel (a lipid profile in the UK) at your next check-up, with a note of any close relative who had early heart disease and a question about adding Lp(a). If a result comes back raised, it's worth asking your doctor or GP when the next test is due and how your overall heart risk has been estimated. Symptoms that are getting worse, or any bleeding 12 months or more after your last period, are reasons to be seen sooner than a routine check. How often you test, whether you ask for Lp(a) and what you change on your plate are yours to decide with your own numbers in hand, because cholesterol care is not one size fits all.